ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1792

Contemporary Racial/Ethnic Disparities in Emergency Department Visits and Hospitalizations for Gout in the United States – 2019 Nationwide Analysis

Chio Yokose1, natalie mccormick2, na lu3, amit johi4, Lesley Jackson5, Minna Kohler6, Janeth Yinh2, yuqing zhang7, John Hsu2, kenneth saag5 and Hyon Choi8, 1Massachusetts General Hospital, Waltham, MA, 2Massachusetts General Hospital, Boston, MA, 3Arthritis Research Canada, Boston, MA, 4Regeneron, Boston, MA, 5University of Alabama at Birmingham, Birmingham, AL, 6Massachusetts General Hospital, Harvard Medical School, Boston, MA, 7Massachusetts General Hospital, Quincy, MA, 8MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

Meeting: ACR Convergence 2022

Keywords: Disparities, Epidemiology, gout, Minority Health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Gout is a highly prevalent inflammatory arthritis with increasing global disease burden in recent years.1,2 A recent analysis3 of the Multiethnic Cohort Study reported that, compared to White individuals, Native Hawaiian, Black, and Japanese-American individuals had 220%, 34%, and 14% higher risk of incident gout while Hispanic individuals had a 22% lower risk. Furthermore, once diagnosed with gout, data show minority patients may be less likely to receive appropriate gout care, such as urate-lowering therapy, in the ambulatory setting.4 How these disparities in background gout risk and suboptimal outpatient care translate into the risk of avoidable and costly health care utilization, such as emergency department (ED) visits and hospitalizations directly due to gout, remains largely unknown. Thus, we sought to examine the contemporary racial/ethnic disparities in ED visits and hospitalizations with a primary discharge diagnosis of gout in the US in 2019.

Methods: Using the latest available data (2019) from the National Emergency Department Sample (NEDS) and National Inpatient Sample (NIS), we compared the racial/ethnic differences in annual population rates of ED visits and hospitalizations for gout (primary discharge diagnosis) per capita (per 100,000 US adults using the 2019 age- and sex-specific US census data). We also examined the rates of ED visits and hospitalizations for gout per total US ED visits/hospitalizations, adjusting additionally for payer, region, and household income.

Results: We identified a total of 196,774 ED visits and 11,485 hospitalizations for a primary diagnosis of gout in the US in 2019 (Table 1). White individuals tended to be older than their racial/ethnic minority counterparts, particularly Asian and Hispanic individuals. The proportion of females tended to be higher among Black adults and lower among Hispanic adults (Table 1). The age- and sex-adjusted rate ratios per capita among US White, Black, Asian, and Hispanic patients for gout-primary ED visits were 1.0, 5.01 (95% CI, 4.96, 5.06), 1.29 (1.26, 1.31), 1.12 (1.10, 1.13) and for gout-primary hospitalizations were 1.0, 4.07 (3.90, 4.24), 1.46 (1.34, 1.58), and 1.06 (0.99, 1.13), respectively (Figure 1). The corresponding ratios per total US ED visits were 1.0, 3.17 (95% CI, 2.86, 3.50), 3.23 (2.71, 3.85), and 1.43 (1.21, 1.68); and per total hospitalizations were 1.0, 2.47 (2.32, 2.64), 3.43 (2.76, 4.72), and 1.21 (1.12, 1.31), respectively (Figure 2). These ratios were the largest among Black women both per capita and per total ED visits/hospitalizations.

Conclusion: These latest nationwide data indicate that gout-primary ED visits and hospitalizations are higher in all racial/ethnic minority patients than non-Hispanic White patients and are particularly high among Black patients. These findings implicate the role of suboptimal gout management for minorities, leading to avoidable healthcare utilization.

References:
1. Safiri et al., PMID 32755051
2. Xia et al., PMID 31624843
3. Thompson et al., PMID 35105711
4. Singh, J. PMID 23315156

Supporting image 1

Supporting image 2


Disclosures: C. Yokose, None; n. mccormick, None; n. lu, None; a. johi, Regeneron; L. Jackson, BHOF; M. Kohler, Setpoint Medical, Springer; J. Yinh, None; y. zhang, None; J. Hsu, None; k. saag, Horizon Therapeutics, SOBI, Shanton, AbbVie/Abbott; H. Choi, Horizon, Allena, LG, Protalix.

To cite this abstract in AMA style:

Yokose C, mccormick n, lu n, johi a, Jackson L, Kohler M, Yinh J, zhang y, Hsu J, saag k, Choi H. Contemporary Racial/Ethnic Disparities in Emergency Department Visits and Hospitalizations for Gout in the United States – 2019 Nationwide Analysis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/contemporary-racial-ethnic-disparities-in-emergency-department-visits-and-hospitalizations-for-gout-in-the-united-states-2019-nationwide-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contemporary-racial-ethnic-disparities-in-emergency-department-visits-and-hospitalizations-for-gout-in-the-united-states-2019-nationwide-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology